Toxins 99, new information about the botulinum neurotoxins

被引：16

作者：

Carruthers, A

Carruthers, J

机构：

[1] Univ British Columbia, Div Dermatol, Vancouver, BC V5Z 1M9, Canada

[2] Univ British Columbia, Dept Ophthalmol, Vancouver, BC V5Z 1M9, Canada

来源：

DERMATOLOGIC SURGERY | 2000年 / 26卷 / 03期

关键词：

D O I：

10.1046/j.1524-4725.2000.00851.x

中图分类号：

R75 [皮肤病学与性病学];

学科分类号：

100206 ;

摘要：

引用

页码：174 / 176

页数：3

共 15 条

[1] Preclinical update on BOTOX® (botulinum toxin type A)-purified neurotoxin complex relative to other botulinum neurotoxin preparations [J].

Aoki, KR .

EUROPEAN JOURNAL OF NEUROLOGY, 1999, 6 :S3-S10

[2]

AOKI KR, 1999, INT C 1999 BAS THER

[3]

AREZZO J, 1999, INT C 1999 BAS THER

[4] Botulinum toxin therapy, immunologic resistance, and problems with available materials [J].

Borodic, G ;

Johnson, E ;

Goodnough, M ;

Schantz, E .

NEUROLOGY, 1996, 46 (01) :26-29

[5]

BRIN MF, 1999, INT C 1999 BAS THER

[6]

CALLAWAY J, 1999, INT C 1999 BAS THER

[7]

COMELLA C, 1999, INT C 1999 BAS THER

[8] Costs of treating dystonias and hemifacial spasm with botulinum toxin A [J].

Dodel, RC ;

Kirchner, A ;

KoehneVolland, R ;

Kunig, G ;

CeballosBaumann, A ;

Naumann, M ;

Brashear, A ;

Richter, HP ;

Szucs, TD ;

Oertel, WH .

PHARMACOECONOMICS, 1997, 12 (06) :695-706

[9]

DOLLY O, 1999, INT C 1999 BAS THER

[10]

FACTOR S, 1999, INT C 1999 BAS THER

← 1 2 →